Related Experiment Videos
[Goal blood pressure values from the nephrologic viewpoint]
1Klinischen Abteilung für Nephrologie und Dialyse, Medizinischen Universitätsklinik III, Wien. walter.hoerl@nephro.imed3.akh-wien.ac.at
Wiener Medizinische Wochenschrift (1946)
|March 18, 2000
Summary
Combination drug therapy is essential for managing hypertension, with fixed-dose combinations improving patient adherence and minimizing side effects. Treatment selection depends on individual health conditions and target blood pressure goals.
Area of Science:
- Pharmacology
- Cardiology
- Nephrology
Context:
- Optimal blood pressure control requires combination drug therapy for most hypertensive patients.
- Fixed-dose combination drugs are preferred for enhancing patient compliance.
- Low dosages of antihypertensive agents minimize adverse effects.
Purpose:
- To outline optimal blood pressure control strategies.
- To discuss the role of combination drug therapy in hypertension management.
- To highlight current blood pressure goals and drug selection criteria.
Summary:
- Combination therapy is necessary for optimal blood pressure control in most hypertensive patients.
- Fixed-dose combinations improve compliance and allow for lower individual drug dosages, minimizing side effects.
- Antihypertensive drug choice is guided by comorbidities, with specific goals for essential hypertension (135/80 mm Hg) and diabetes/renal diseases (120/70 mm Hg).
- Angiotensin-converting enzyme (ACE) inhibitors or angiotensin II blockers are preferred for patients with renal disease.
Impact:
- Improved patient adherence and reduced side effects through fixed-dose combinations.
- Personalized treatment strategies based on comorbidities and blood pressure targets.
- Enhanced management of hypertension, particularly in patients with diabetes or renal involvement.